Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: report of a case F Hindilerden, I Yonal-Hindilerden, E Akar, K Kart-Yasar Thrombosis research 195, 136, 2020 | 69 | 2020 |
Severe autoimmune hemolytic anemia in COVID-19 infection, safely treated with steroids F Hindilerden, I Yonal-Hindilerden, E Akar, Z Yesilbag, K Kart-Yasar Mediterranean journal of hematology and infectious diseases 12 (1), 2020 | 54 | 2020 |
Clinicopathological characteristics, prognosis and survival outcome of gastric cancer in young patients: a large cohort retrospective study K Tekesin, ME Gunes, D Tural, E Akar, A Zirtiloglu, M Karaca, ... future 1 (3), 2019 | 40 | 2019 |
P95 HER2 fragments and breast cancer outcome D Tural, E Akar, H Mutlu, S Kilickap Expert review of anticancer therapy 14 (9), 1089-1096, 2014 | 40 | 2014 |
Herbal administration and interaction of cancer treatment D Arslan, D Tural, E Akar Journal of palliative medicine 16 (11), 1466-1476, 2013 | 40 | 2013 |
Cancer pain prevalence and its management D Arslan, T Koca, E Akar, D Tural, M Ozdogan Asian Pacific journal of cancer prevention 15 (20), 2014 | 32 | 2014 |
Isolated uterine metastasis of invasive ductal carcinoma D Arslan, D Tural, AM Tatlı, E Akar, M Uysal, G Erdoğan Case reports in oncological medicine 2013, 2013 | 29 | 2013 |
Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS D Tural, S Batur, S Erdamar, E Akar, N Kepil, NM Mandel, S Serdengeçti Tumor Biology 35, 1041-1049, 2014 | 24 | 2014 |
Gastric cancer: A case study in Turkey D Tural, F Selçukbiricik, E Akar, S Serdengeçti, E Büyükünal Journal of Cancer Research and Therapeutics 9 (4), 644-648, 2013 | 15 | 2013 |
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: results of real-life experiences D Tural, ÖF Ölmez, AT Sümbül, M Artaç, N Özhan, E Akar, B Çakar, ... European urology focus 7 (5), 1061-1066, 2021 | 14 | 2021 |
Severe liver dysfunction and safe use of 5-fluorouracil leucovorin and oxaliplatin in one patient with metastatic colorectal carcinoma D Tural, E Akar, MA Öztürk, Ö Yıldız, H Turna, S Serdengeçti Journal of cancer research and therapeutics 10 (3), 745-748, 2014 | 11 | 2014 |
PET-CT changes the management and improves outcome in patients with recurrent colorectal cancer D Tural, F Selçukbiricik, S Sager, E Akar, O Yildiz, S Serdengeçti Journal of Cancer Research and Therapeutics 10 (1), 121-126, 2014 | 11 | 2014 |
Hepatitis B reactivation rate is higher undergoing some cytotoxic chemotherapy in patients with solid tumors: a large retrospective study M Karaca, D Tural, E Akar, İ Çil, S Bayrak, G Ozet, OK Yucel, E Hocaoglu, ... Chemotherapy 63 (5), 247-252, 2019 | 8 | 2019 |
PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies K Tekesin, M Emin Gunes, S Bayrak, E Akar, T Ozturk, S Altinay, D Tural J buon 24 (5), 1920-6, 2019 | 8 | 2019 |
Safe use of nivolumab in a patient with renal cell carcinoma and hepatitis B E Akar, HF Baytekin, H Deniz, D Tural Journal of Oncology Pharmacy Practice 26 (4), 1022-1024, 2020 | 6 | 2020 |
Relationship between survival outcomes and microsatellite instability, tumor infiltrating lymphocytes and programmed cell death ligand-1 expression in patients with bladder … D Tural, E Akar, HF Baytekin, D Canoglu, M Yilmaz, V Tugcu J buon 26 (5), 2117-25, 2021 | 4 | 2021 |
Retrospective analysis of survival in patients with brain metastases from an unknown primary tumor M Cirak, DG Guclu, E Akar, MH Kazanci, D Tural Turk Neurosurg 30 (6), 932-936, 2020 | 4 | 2020 |
Hepatitis D reactivation in a patient with metastatic renal cell carcinoma receiving sunitinib therapy E Akar, MH Yücel, T Şahin, D Tural Tumori Journal 105 (6), NP72-NP74, 2019 | 4 | 2019 |
Late relapse of testicular cancer: Recurrence after 24 years and treatment with chemotherapy alone E Akar, D Tural, D Arslan, Cİ Başsorgun, Ö Yıldız Journal of Cancer Research and Therapeutics 11 (3), 661, 2015 | 4 | 2015 |
Malignant clinical presentation of a benign granular cell tumor of breast in a patient with previously treated contralateral invasive ductal carcinoma D Tural, E Akar, T Öztürk, H Turna, S Serdengeçti Case Reports in Oncological Medicine 2012, 2012 | 4 | 2012 |